Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications

BJOG. 2013 Oct;120(11):1440. doi: 10.1111/1471-0528.12280.

Authors

U Winterfeld¹, A Allignol, A Panchaud, L E Rothuizen, P Merlob, B Cuppers-Maarschalkerweerd, T Vial, S Stephens, M Clementi, M De Santis, A Pistelli, M Berlin, G Eleftheriou, E Maňáková, T Buclin

Affiliation

¹ STIS and Division of Clinical Pharmacology and Toxicology, University Hospital, Lausanne, Switzerland.

PMID: 24034523
DOI: 10.1111/1471-0528.12280

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Maternal Exposure / adverse effects*
Pregnancy
Pregnancy Outcome / epidemiology*
Teratogens*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Teratogens